Top 10 Healthcare Equipment Stocks To Watch Right Now


Nam Y. Huh/AP NEW YORK — U.S. consumer sentiment slid in September to its lowest in five months as consumers saw higher interest rates and sluggish economic growth ahead, a survey released Friday showed. The Thomson Reuters/University of Michigan’s final reading on the overall index on consumer sentiment slipped to 77.5 in September from 82.1 in August — the lowest final reading since April. The September figure was lower than the 78.0 economists had expected in a Reuters poll, but higher than a mid-month preliminary reading of 76.8. Looming Congressional showdowns over a possible government shutdown and the need to raise the debt ceiling or else face the possibility of default have renewed worries about fiscal policy and legislative gridlock. “While few consumers expected a federal shutdown, complaints about government policies have risen, and more importantly, prospects for job growth have diminished,” survey director Richard Curtin said in a statement. Other gauges also hit their lowest final reading since April: the gauge of consumer expectations, at 67.8, and the index of current conditions, at 92.6. While the U.S. Federal Reserve decided this month not to pull back on its massive bond-buying program yet, analysts still see the Fed scaling back in coming months. Those views, in turn, have helped push up long-term interest rates by more than a full percentage point since May, with 30-year mortgage rates recently hitting a year high of 4.80 percent. Economists fear consumer sentiment could weaken further if higher interest rates start to slow momentum in a housing revival that has been one of the brightest spots in the overall U.S. recovery. The one-year inflation expectation rose to 3.3 percent from 3.0 percent while the five-to-10-year inflation outlook edged up to 3.0 percent from 2.9 percent.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Madison Covered Call & Equity Strategy Fund (MCN)


Madison/Claymore Covered Call & Equity Strategy Fund (the Fund), formerly Madison/Claymore Covered Call Fund, is a diversified, closed-end management investment company. The Fund’s primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Fund invests in a portfolio consisting primarily of large capitalization common stocks. The Fund will sell covered call options to seek to generate a reasonably steady production of option premiums.

Madison Asset Management, LLC is the Fund’s investment manager. Madison Asset Management, LLC is a wholly owned subsidiary of Madison Investment Advisors, Inc.


Advisors’ Opinion:

  • [By Robert Hsu]

    Here are four to consider:

    PowerShares S&P 500 BuyWrite ETF (PBP), yielding 4.09%

    Madison/Claymore Covered Call & Equity Strategy (MCN), yielding 8.94%

    Nuveen Equity Premium Opportunity Fund (JSN), yielding 9.19%

    BlackRock Enhanced Dividend Achievers (BDJ), yielding 7.39%

    The yield on these funds is very attractive. Even more attractive is the fact that many buy-write funds actually are selling at a discount to their net asset value.

  • [By Robert Hsu]


    Name Type of Security  Recommendation  Kinder Morgan Energy Partners L.P. (NYSE: KMP)   MLP August 15, 2013  TeeKay LNG Partners L.P.  (NYSE: TGP)   MLP September 16, 2013  PowerShares S&P 500 BuyWrite Portfol ETF  (NYSE Arca: PBP)  Buy-Write ETF September 30, 2013  Madison Covered Call Equity Strtgy Fd (NYSE: MCN)  Buy-Write ETF September 30, 2013  Nuveen Equity Premium Opportunity Fund (NYSE: JSN)  Buy-Write ETF September 30, 2013  BlackRockEnhanced Dividend Achievers Tr (NYSE: BDJ)  Buy-Write ETF September 30, 2013  Vornado Realty Trust   (NYSE: VNO)  Real Estate
    Investment
    Trust September 26, 2013 


    Robert Hsu is the editor of Permanent Wealth Investor and a former hedge fund portfolio manager at Wall Street powerhouse Goldman Sachs. He retired from Goldman at age 31. He since has come out of retirement to establish and preside over his money management firm, Absolute Return Capital Advisors. His retirement experience has given him his current mission: helping investors like you achieve their goal of comfortable retirement through profitable income strategies.

Top 10 Healthcare Equipment Stocks To Watch Right Now: American Heritage International Inc (AHII)


American Heritage International Inc., formerly Cumberland Hills Ltd., incorporated on January 19, 2010, intends to focus on electronic cigarette. The Company’s product includes American Heritage, American One, American Freedom, American Nights, American Standard and Smoking Alternative Gums and Mints.

The Company’s initial and primary line will be the American Heritage line. American One is a disposable Electronic Cigarette, good for over 500 draws, about the equivalent of over two packs of traditional cigarettes. American Freedom will be the brand name for its Nicotine-Free line of Electronic Cigarettes. American Nights will be a product line targeted to the young adult market of social smokers. Smoking Alternative products will include gums, and mints.


Advisors’ Opinion:

  • [By James E. Brumley]

    Fans and investors of American Heritage International Inc. (OTCBB:AHII) – not to mention frenemies Vapor Corp. (OTCMKTS:VPCO) and Victory Electronic Cigarettes Corp. (OTCMKTS:ECIG) – can all breathe a sigh of relief today. As it turns out, while the electronic cigarette industry is more than likely be regulated by the FDA, it’s going to be regulated in such a way that tends to favor the likes of AHII, ECIG, and VPCO.

  • [By Bryan Murphy]

    Every cigarette company from Altria Group Inc. (NYSE:MO) to Victory Electronic Cigarettes Corp. (OTCMKTS:ECIG) will want to take notice of this morning’s news from American Heritage International Inc. (OTCBB:AHII) – the young startup’s electronic cigarettes now have something else great going for them. As such, it just got a little easier for smokers to justify dumping traditional tobacco cigarettes like those made by Altria (like Marlboro) in favor of e-cigs….

Top 10 Healthcare Equipment Stocks To Watch Right Now: American Express Company(AXP)


American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company?s product portfolio consists of charge and credit card products; expense management products and services; consumer and business travel services; stored value cards, including travelers cheques and other prepaid products; network services; merchant acquisition and processing, point-of-sale, servicing and settlement, and marketing and information products and services for merchants; and fee services comprising market and trend analyses and related consulting services, fraud prevention services, and the design of customer loyalty and rewards programs. In addition, it publishes luxury lifestyle magazines; business and travel resources; general interest, cooking, travel, wine, cocktail, financial, and time management books; and international and electronic editions. The company sells its products and services to consumer s, small businesses, mid-sized companies, and large corporations through direct mail, on-line applications, targeted direct and third-party sales forces, and direct response advertising worldwide. American Express Company was founded in 1850 and is headquartered in New York, New York.


Advisors’ Opinion:

  • [By James O’Toole]

    Despite gaining powerful backers like American Express (AXP) and JPMorgan (JPM), the service has failed to catch on, and it faces competition from the likes of Google Wallet, PayPal, Square, Venmo and many others.

  • [By MONEYMORNING.COM]

    Nelms is not alone. The heads of American Express Co. (NYSE: AXP), Visa Inc. (NYSE: V) and MasterCard Inc. (NYSE: MA) have all been dismissive regarding any adverse impact the growth of Bitcoin might have on their businesses.

  • [By Dan Caplinger]

    The Dow Jones Industrials (DJINDICES: ^DJI  ) is well known for giving income investors the dividend increases they like to see. All 30 Dow stocks pay dividends, and many of them consistently increase their quarterly payouts year after year. Interestingly, though, the timing of those dividend increases throughout the year reflects uneven patterns. After American Express (NYSE: AXP  ) and Caterpillar (NYSE: CAT  ) pay out their recently declared higher dividends in the next couple of weeks, Dow investors could go quite a while without seeing another increase.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Portfolio Recovery Associates Inc.(PRAA)


Portfolio Recovery Associates, Inc., a financial and business service company, engages in the purchase, collection, and management of portfolios of defaulted consumer receivables. It detects, collects, and processes unpaid and normal-course accounts receivables owed primarily to credit grantors, governments, and retailers. The company also acquires receivables of Visa, MasterCard, and other credit cards; private label credit cards; installment loans; lines of credit; bankrupt accounts; deficiency balances of various types; legal judgments, and trade payables from various debt owners, including banks, credit unions, consumer finance companies, telecommunication providers, retailers, utilities, insurance companies, medical groups, hospitals, auto finance companies, and other debt buyers. In addition, it provides fee-based services, including vehicle location, skip tracing, and collateral recovery services for auto lenders, governments, and law enforcement; revenue administra tion, audit, and debt discovery/recovery services for local government entities; and class action claims recovery services and related payment processing services. The company was founded in 1996 and is headquartered in Norfolk, Virginia.


Advisors’ Opinion:

  • [By James Brumley]

    As is so often the case, however, the market’s activity of late has been more random and coincidental than rational or calculated. Translation: Don’t read too much into the pullback from small-cap stocks. In fact, that pullback appears to have created some strong buying opportunities among the Russell 2000′s constituents. Here are four such small caps that bargain-hunters may want to consider first.

    Portfolio Recovery Associates (PRAA)

    For better or worse, collecting bad debts is a business that will never go out of style. That’s why Portfolio Recovery Associates (PRAA) is a solid all-weather play, particularly after shares of PRAA stock sank nearly 25% between October and February. Shares have made a modest recovery effort since then, but most of the rebound meat is still left on the bone.

  • [By Lawrence Meyers]

    The other good news is on pages 10, 11 and 15. Delinquencies are rising, as are collections. If debt balances increase, you would expect delinquencies to rise as well. That bodes well for the big-time players in debt collection, Portfolio Recovery Associates (PRAA) and Encore Capital Group (ECPG). Both just reported robust growth in collections, revenues, and net income. They’re also making large international acquisitions. I love both companies and think they’re are undervalued.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Mueller Water Products Inc (MWA)


Mueller Water Products, Inc., incorporated on September 22, 2005, is a manufacturer and marketer of products and services used in the transmission, distribution and measurement of water. The Company’s product portfolio includes engineered valves, fire hydrants, pipe fittings, water meters, leak detection and pipe condition assessment which are used by municipalities, as well as the residential and non-residential construction industries. The Company operates in two segments: Mueller Co. and Anvil. Mueller Co. The Company’s valve or fire hydrant products are specified for use in the 100 metropolitan areas in the United States.


Mueller Co.

Mueller Co. manufactures valves for water and gas systems, including iron gate, butterfly, tapping, check, plug and ball valves, as well as dry-barrel and wet-barrel fire hydrants and a of pipe repair products, such as clamps and couplings used to repair leaks. The Company offers residential and commercial me tering products and systems and leak detection and pipe condition assessment products and services. Mueller Co. products are sold through waterworks distributors.

The Company’s fire hydrants consist of an upper barrel and nozzle section and a lower barrel and valve section that connects to a water main. In dry-barrel hydrants, the valve connecting the barrel of the hydrant to the water main is located below ground at or below the frost line, which keeps the hydrant upper barrel dry. It sells dry-barrel fire hydrants with the Mueller and U.S. Pipe Valve and Hydrant brand names in the United States and the Mueller and Canada Valve brand names in Canada. The Company also makes wet-barrel hydrants, where the valves are located in the hydrant nozzles and the barrel contains water at all times. It also makes wet-barrel hydrants, where the valves are located in the hydrant nozzles and the barrel contains water at all times.


Mueller Co. manufactures a va riety of intelligent water technology products under the Mue! ller Systems and Hersey Meters brand names that are designed to help water providers accurately measure water usage. These products include water meters, advanced metering infrastructure systems and automated meter reading products, have the capability to measure water usage ranging from small residential flows to large commercial and industrial applications.

Mueller Co. offers leak detection and pipe condition assessment products and services under the Echologics brand name. Other products include pipe repair products, such as clamps and couplings used to repair leaks and municipal castings, such as manhole covers and street drain grates. It sells these products under the Mueller and Jones brand names.


The Company competes with McWane, Inc., American Cast Iron Pipe Company, The Ford Meter Box Company, Inc., A.Y. McDonald Mfg, Sensus, Neptune Technology Group, Inc., Badger Meter, Inc., Aclara LLC and Itron, Inc.

Anvil

Anvi l manufactures and sources a range of products, includes fittings, couplings, hangers, valves and related products for use in many non-residential constructions for HVAC, fire protection, energy and oil and gas applications. Anvil’s products are sold through distributors who then sell the products to a variety of end users. These distributors are serviced primarily through Anvil’s distribution centers.


Fittings and Couplings manufactures threaded and grooved pipe fittings and couplings. Pipe fittings and couplings join two pieces of pipe together. The five categories of pipe fittings and couplings are cast iron fittings, malleable iron fittings and unions, grooved fittings, couplings and valves, threaded steel pipe coupling and nipples. Hangers, manufacture an array of pipe hangers and supports. Standard pipe hangers and supports are used in fire protection sprinkler systems and HVAC applications where the objective is to provide rigid support from the building structure.


The Company competes with Ward Man! ufacturin! g L.L.C., malleable iron fittings, Victaulic Company, Tyco International Ltd., ERICO International Corporation, Cooper Industries plc and Carpenter & Paterson, Inc.

Advisors’ Opinion:

  • [By Travis Hoium]

    What: Shares of Mueller Water Products (NYSE: MWA  ) jumped as much as 17% today after the company released earnings.

    So what: Fiscal-second-quarter revenue jumped 12.6% to $283.1 million and net income was $6.2 million, or $0.05 per share. Analysts only expected revenue to be $270.8 million and earnings of $0.02 per share so this was well ahead of estimates.  

Top 10 Healthcare Equipment Stocks To Watch Right Now: China Fund Inc (CHN)


The China Fund, Inc. (the Fund), incorporated on April 28, 1992, is a non-diversified, closed-end management investment company. The Fund’s investment objective is to achieve long-term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in the People’s Republic of China, or which derive a significant part of their revenue from the People’s Republic of China.

The China Fund, Inc. may invest in equity-linked securities, such as linked participation notes, equity swaps and zero-strike options, and securities warrants collectively referred to as Access Products. The Fund invests various sectors, including industrials, consumer discretionary, energy, information technology, financials, consumer staples, materials, utilities, healthcare and telecommunications. Martin Currie Inc. serves as the investment manager for the Fund’s listed assets. Asi an Direct Capital Management is the investment manager for the Fund’s assets allocated to direct investments.


Advisors’ Opinion:

  • [By Stephen Leeb, Founder and Research Chairman, Leeb Group]

    Healthy economic data, coupled with low inflation, make Chinese stocks attractive as well. Our first choice here is the China Fund (CHN). It holds a diverse portfolio of stocks primarily focused on the Chinese domestic market.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Redpoint Bio Corp (RPBC)

Redpoint Bio Corporation (Redpoint), incorporated in August 1995, is a development-stage biotechnology company. The Company leverages discoveries in the molecular biology of taste to discover and develop taste modulators for the food and beverage industries. Its food and beverage program has been focused on identifying flavor modifiers that improve the taste of ingredients. In June 2009, the Company announced that it had identified an all-natural sweetness enhancer, RP44. RP44 is Reb-C (rebaudioside C), a component of the stevia plant.


Sweetness Enhancer Program

Redpoint announced that it had identified RP44, an all-natural sweetness enhancer, in June 2009. In January 2010, it disclosed that RP44 is Reb-C (rebaudioside C), a component of the stevia plant. RP44 is derived from material found in the side stream of the Reb A production process. A purified component of stevia known as Reb A has received regulatory approval in the United States. Unlik e Reb A, RP44 has a low intrinsic level of sweetness and therefore is not useful as a sweetener.

Diabetes and Obesity Drug Discovery Program


The Company’s initial programs focused on the modulation of the TRPm5 ion channel, a signaling element in taste sensation, in order to discover compounds that modulate the taste of food and beverage products. Redpoint initiated a program designed to leverage the research it had already conducted on the discovery of modulators of the TRPm5 ion channel to further explore opportunities for the discovery of diabetes or obesity therapeutics. TRPm5 modulators discovered at Redpoint have been shown to elicit the secretion of hormones known to play roles in metabolism in relevant model systems.


The Company competes with International Flavors & Fragrances Inc., Givaudan SA, Symrise, Firmenich, Senomyx, PureCircle Ltd, GLG Life Tech Corporation, Eli Lilly and Company, Amylin Pharmaceuticals, Merck & Co., Inc., Metabolex, Inc., OSI Pharmaceuticals, GlaxoSmithKline! , Arena Pharmaceuticals, Inc. and Johnson & Johnson.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks Greenfield Farms Food Inc (OTCMKTS: GRAS), International Stem Cell Corp (OTCMKTS: ISCO) and Redpoint Bio Corporation (OTCMKTS: RPBC) have all been getting some extra attention lately in various investment newsletters. However, none of these small cap stocks appear to have been the subject or paid promotions or investor relations activities. So does that make any of them good bets for traders and investors alike? Here is a quick look and a reality check:

Top 10 Healthcare Equipment Stocks To Watch Right Now: Audience Inc (ADNC)


Audience, Inc., incorporated on May 24, 2011, is a provider of voice and audio solutions that improve voice quality and the user experience in mobile devices. The Company’s solutions include hardware-accelerated digital signal processors (DSPs), and audio codecs and associated algorithms for noise suppression in mobile devices. Its computational auditory scene analysis (CASA) maps the sound separation functions in human hearing, into a computational framework. The Company’s platform consists of its DSPs and audio codec, analog and mixed signal circuits and algorithms for voice isolation and noise suppression.


The Company also provides its AuViD graphical design tools to original equipment manufacturers (OEMs). The Company had sold over 250 million processors to its OEM customers as of December 31, 2012. In addition to the mobile device market, the Company’s voice and audio technology is also applicable to a range of other market segments, including automobile infotainment systems, digital cameras, digital televisions, headsets and set top boxes.

The Company’s product portfolio supports both analog and digital interfaces. As of December 31, 2012, the Company offered eS515, eS325, eS305, eS310, eS110, A1028 and A1026 custom voice and audio processors for device platforms, including smartphones, feature phones and media tablets. eS515 is a third generation voice and audio processor with an integrated audio codec, featuring support of three-microphones; eS325is a third generation voice and audio processor that features simultaneous three microphone processing; eS305 is a second generation voice and audio processor utilizing new hardware acceleration architecture and algorithms for far-field, wideband communications and capable of advanced speech recognition assist, and uses an all digital interface; eS310, provides similar capabilities to the eS305; eS110 is a first generation narrowband voice processor designed for re al-time communications and far-field as well as near-field u! se with features such as acoustic echo cancelation, voice equalization and automatic gain control; A1026, is a first generation narrowband voice processor designed for real-time communications and typical near-field use, and A1028, which is a first generation narrowband voice processor designed for real-time communications and far-field, as well as near-field use.


The Company derives its revenue primarily from the sale of voice and audio processors to OEMs, which incorporate them into mobile devices. As of December 31, 2012, OEMs, CMs and distributors worldwide had purchased more than 250 million of its processors and incorporated them in over 140 mobile device models.

The Company competes with Maxim, ON Semiconductor, Qualcomm, Texas Instruments Incorporated, Wolfson Microelectronics plc, DSP Group, Inc. and Yamaha Corporation.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Audience (Nasdaq: ADNC  ) , whose recent revenue and earnings are plotted below.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Cyberonics Inc (CYBX)


Cyberonics, Inc. (Cyberonics), incorporated in 1987, is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters for each patient; instruction manuals, and magnets to suspend or induce stimulation manually. The VNS Therapy pulse generator and lead are surgically implanted into patients generally during an outpatient procedure. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and sof tware and a tunneling tool.


The United States Food and Drug Administration (FDA) approved the Company’s VNS Therapy System in July 1997 for use as an adjunctive therapy in epilepsy patients over 12 years of age for reducing the frequency of partial onset seizures that are refractory or resistant to antiepileptic drugs. Regulatory bodies in Canada, the European Economic Area, certain countries in Eastern Europe, Russia, South America, Africa, Australia and certain countries in Asia, including Japan, China and Taiwan, have approved the VNS Therapy System for the treatment of epilepsy, many without age restrictions or seizure-type limitations. In July 2005, the FDA approved the Company’s VNS Therapy System for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a depressive episode and have not had an adequate response to four or more adequate anti-depressant treatments. Regulatory bodies in the European Economic Area, Canada and Israel have approv! ed the Company’s VNS Therapy System for the treatment of chronic or recurrent depression in patients who are in a treatment-resistant or treatment-intolerant depressive episode without age restrictions.


In February 2011, the Company announced FDA approval of its fifth generation generator, the AspireHC generator. In August 2011, the Company announced that the Company discovered a hardware-related design issue with the AspireHC Model 105 and AspireSR (Seizure Response) Model 106 generators. In December 2011, the FDA approved the Company’s re-designed AspireHC generator, and the Company resumed its limited commercial release of the generator in the United States.

Pulse Generator

The pulse generator is an implantable, programmable signal generator designed to be coupled with the bipolar lead to deliver mild electrical pulses to the vagus nerve. The pulse generator is a battery-powered device. Before or upon depletion of the battery, the pu lse generator may be removed and a new generator implanted in a short, outpatient procedure. The Model 102 (Pulse), Model 102R (Pulse Duo ), Model 103 (Demipulse), Model 104 (Demipulse Duo) and Model 105 (AspireHC), are the VNS Therapy pulse generators the Company offers and are similar in design and manufactures to a cardiac pacemaker.


Bipolar Lead

The bipolar lead conducts the electrical signal from the pulse generator to the vagus nerve. The lead incorporates electrodes, which are self-sizing, minimizing mechanical trauma to the nerve. The lead’s two electrodes and anchor tether wrap around the vagus nerve, and the connector end is tunneled subcutaneously to the upper chest area, where it attaches to the pulse generator. The Company offers three lead models in the United States. The leads are available in two inner spiral diameter sizes to ensure optimal electrode placement on different-sized nerves.


Programming Wand and Software

The Company’s programming wand and software are us! ed to int! errogate the implanted pulse generator and to transmit programming information from a handheld computer to the pulse generator via an inductive coupling. Programming capabilities include modification of the pulse generator’s programmable parameters (pulse width, amplitude and frequency and stimulation ON and OFF intervals) and storage and retrieval of telemetry data.

Tunneling Tool

The tunneling tool is a single use, sterile, disposable surgical tool designed to be used during surgical placement of the bipolar lead. The tool is used for subcutaneous tunneling of the lead between the nerve site in the neck and the pulse generator site in the upper chest area.


Accessory Pack

The accessory pack includes two resistor assemblies used to test the function of the device prior to implantation, the bipolar lead tie-downs and one hex screwdriver. The patient kit includes two magnets, one watch-style and one pager-style.

The Company competes with Medtronic, Inc., NeuroSigma Inc. and CerboMed GmbH.

Advisors’ Opinion:

  • [By James E. Brumley]

    Investors who were hoping things would work out for epilepsy treatment company Cyberonics, Inc. (NASDAQ:CYBX) can cross CYBX off their list of epilepsy-oriented stocks to buy, as they did with Acorda Therapeutics Inc. (NASDAQ:ACOR) about a month ago. ACOR saw its epilepsy drug Plumiaz rejected by the FDA in early May, while CYBX announced this morning that the coming fiscal year’s (beginning in April) revenue would be weaker than first expected as sales of its epileptic control implant device didn’t look quite as promising as hoped.

  • [By Benjamin Shepherd]

    The rise of public health services, improvements in sanitation and access to clean drinking water have led to a huge improvement in human life expectancy, which has jumped from only about 30 years five centuries ago to more than 75 years in most industrialized countries today.

    Advances in medical science have also played a major role, such as the development of antibiotics to treat once deadly infections, surgical interventions to correct once fatal injuries and medications to treat chronic conditions.

    We have yet to reach the limit of human ingenuity and today the trend is towards harnessing technology to break the reliance on long-term medication usage to treat chronic conditions. One area where huge strides are being made in that direction is the treatment of epilepsy.


    Epilepsy is the fourth most common neurological disease in the world, affecting more than 9 million people in developed countries alone, and epileptics have a mortality rate more than 25 times higher than the general population. The costs associated with dealing with the disease run in excess of $13.5 billion in the US alone.

    The disease is typically treated using a drug regime that includes several pills a day, including anti-convulsants and sedatives which can have unpleasant side effects. Drug therapy is typically successful in controlling seizures in about 70 percent of patients, but about a third of those who don’t respond to medication find themselves undergoing surgery to essentially remove the area of the brain triggering the seizures.

    Cyberonics (NSDQ: CYBX) is making headway into an alternative treatment for the disease, called vagus nerve stimulation (VNS) therapy, which can reduce the number or even eliminate the need for the drugs epileptics depend upon and requires only minor surgery.

    During an outpatient procedure conducted under general anesthesia, two small incisions are made, one in the upper chest area and the ot her in the neck. At t

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Cyberonics (Nasdaq: CYBX  ) , whose recent revenue and earnings are plotted below.

Top 10 Healthcare Equipment Stocks To Watch Right Now: Vishay Intertechnology Inc. (VSH)

Vishay Intertechnology Inc. designs, manufactures, and supplies discrete semiconductors and passive components. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors. The MOSFETs segment offers low- and medium-voltage TrenchFET MOSFETs, high-voltage planar MOSFETs, high voltage Super Junction MOSFETs, power integrated circuits, and integrated function power devices. The Diodes segment provides rectifiers, small signal diodes, protection diodes, thyristors/silicon-controlled rectifiers, and power modules. The Optoelectronic Components segment offers infrared (IR) emitters and detectors, IR remote control receivers, optocouplers, solid-state relays, optical sensors, light-emitting diodes, seven-segment displays, and IR data transceiver modules. The Resistors & Inductors segment provides film, wirewound, power metal strip, variable, and non-linear resistors, as well as battery management shunts, chip fuses, ne tworks/arrays, magnetics, and connectors. The Capacitors segment offers tantalum, ceramic, film, power, heavy-current, and aluminum capacitors. The company’s semiconductor components are used for various functions, including power control, power conversion, power management, signal switching, signal routing, signal blocking, signal amplification, two-way data transfer, one-way remote control, and circuit isolation; and passive components are used to restrict current flow, suppress voltage increases, store and discharge energy, control alternating current and voltage, filter out unwanted electrical signals, and perform other functions. It serves industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets. Vishay Intertechnology offers its products to the manufacturers primarily in the United States, Europe, and Asia. The company was founded in 1962 and is headquartered in Malvern, Pennsylvania.

Advisors’ Opinion:

  • [By Bryan Murphy]

    When most investors think of optical sensor makers, they tend to think of larger names like Honeywell International Inc.  (NYSE:HON) or Vishay Intertechnology (NYSE:VSH). And well they should. VSH is a $2 billion company, and HON is a $71.5 billion organization. The fact is, however, there are a few small cap stocks in the optical sensor space that are worth a look, and one of them is worth a very close look right now for a very clear reason… Advanced Photonix, Inc. (NYSEMKT:API).

  • [By Seth Jayson]

    Vishay Intertechnology (NYSE: VSH  ) reported earnings on April 30. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 30 (Q1), Vishay Intertechnology beat expectations on revenues and beat expectations on earnings per share.